Developing UK Vaccine Supply Chain Resilience for Covid and Potential Future Health Emergencies – Single Use Technologies, Biobags and Filters

The Covid-19 pandemic has prompted inspiring collaboration between industry, academia, and government to discover, develop, manufacture and distribute vaccines. It has also demonstrated what level of response to demand is possible within existing supply chains. To build on this, the UK Government is developing a strategy which seeks to increase the UK’s vaccine supply resilience and on-shore manufacturing capability in response to Covid-19 and potential future health emergencies. As part of the strategy, the UK Vaccine Taskforce (VTF, a joint unit of BEIS & DHSC) is engaging the market to build its understanding of barriers, risks and opportunities to meet future demand and build resilience in the UK vaccines supply chains. The information gathered will be used to inform decisions about how the VTF can best facilitate companies to invest in increasing UK-based capacity and capability within key component areas used in vaccine manufacturing, to provide resilience and onshoring capacity